Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Biogen inks $1B RayThera buyout to bag preclinical immunology assets

Biogen inks $1B RayThera buyout to bag preclinical immunology assets

  • June 18, 2026

Biogen has struck a backloaded, $1 billion deal to buy RayThera, snagging a pipeline of anti-inflammatory drug candidates led by a prospect on the cusp of clinical development.

Leave A Comment

Fields (*) Mark are Required